Global disparities in cancer supportive care: An international survey-Reference-Cited by-同舟云学术

Global disparities in cancer supportive care: An international survey

Published:2024-09 Issue:17 Volume:13 Page:
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Chan Alexandre¹²^ORCID,Eng Lawson³,Jiang Changchuan⁴^ORCID,Dagsi Mary¹,Ke Yu²,Tanay Mary⁵,Bergerot Cristiane⁶,Dixit Niharika⁷,Gutiérrez Ana Cardeña⁸^ORCID,Velazquez Ana I.⁹^ORCID,Islami Farhad¹⁰,Soto‐Perez‐de‐Celis Enrique¹¹¹²

Affiliation:

1. School of Pharmacy & Pharmaceutical Sciences University of California Irvine Irvine USA

2. National Cancer Centre Singapore Singapore Singapore

3. Division of Medical Oncology and Hematology, Department of Medicine Princess Margaret Cancer Centre/University Health Network, University of Toronto Toronto Ontario Canada

4. Division of Hematology and Oncology, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA

5. Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London London UK

6. Oncoclinicas Brasilia DF Brazil

7. University of California, San Francisco/Zuckerberg San Francisco General Hospital San Francisco California USA

8. Medical Oncology Department Hospital Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife Spain

9. University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco California USA

10. Surveillance and Health Equity Science, American Cancer Society Atlanta Georgia USA

11. Department of Geriatrics Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City Mexico

12. Division of Medical Oncology University of Colorado Anschutz Medical Campus Aurora Colorado USA

Abstract

AbstractBackgroundThe global cancer burden is rising, particularly in low‐ and middle‐income countries (LMIC), highlighting a critical research gap in understanding disparities in supportive care access. To address this, the Multinational Association of Supportive Care in Cancer (MASCC) Health Disparities Committee initiated a global survey to investigate and delineate these disparities. This study aims to explore and compare supportive care access disparities between LMIC and High‐Income Countries (HIC).MethodsAn online cross‐sectional survey was conducted among active members of MASCC. Members, representing diverse healthcare professions received email invitations. The survey, available for 3 weeks, comprised sections covering (1) sociodemographic information; (2) clinical service/practice‐related disparities in their region/nation; (3) population groups facing disparities within their region or country. Chi‐squared or Fisher's exact test for cross‐sectional analyses, and a multivariable logistic regression model was employed for statistical analysis.ResultsA total of 218 active members participated, with one‐quarter (26.6%) from LMIC and 18.4% ethnic minorities, timely cancer care (43.7%) and timely supportive care (45.0%) emerged as the most pressing disparities globally. Notably, participants from LMIC underscored cancer drug affordability (56.4%) and supportive care guideline implementation (56.4%) as critical issues. Economically disadvantaged populations were noted as more likely to face disparities by both LMIC and HIC (non‐US‐based) respondents, while US‐based respondents identified racial/ethnic minorities as facing more disparities.ConclusionThis global survey reveals significant disparities in cancer supportive care between LMIC and HIC, with a particular emphasis on medication affordability and guideline implementation in LMIC. Addressing these disparities requires targeted intervention, considering specific regional priorities.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.70234

Reference36 articles.

1. Cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA;Global Burden of Disease Cancer C;Oncologia,2022

2. Supportive care in cancer—a MASCC perspective

3. Supportive-expressive group therapy for women with metastatic breast cancer: survival and psychosocial outcome from a randomized controlled trial

4. Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial

5. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer